Literature DB >> 1586268

Positive antinuclear antibodies in malignancies.

M Zuber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1586268      PMCID： PMC1004723          DOI： 10.1136/ard.51.4.573-b

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  7 in total

1.  Detection of immunoglobulin G antibodies in melanoma sera reactive with intracellular proteins.

Authors:  E Bonfa; J C Bystryn; K B Elkon
Journal:  J Invest Dermatol       Date:  1988-02       Impact factor: 8.551

2.  The diagnostic associations of patients with antinuclear antibodies referred to a community rheumatologist.

Authors:  W C Shiel; M Jason
Journal:  J Rheumatol       Date:  1989-06       Impact factor: 4.666

Review 3.  Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine.

Authors:  E M Tan
Journal:  Adv Immunol       Date:  1982       Impact factor: 3.543

4.  Raynaud's phenomenon and positive antinuclear antibodies in a malignancy.

Authors:  C Tolosa-Vilella; J Ordi-Ros; M Vilardell-Tarres; A Selva-O'Callaghan; R Jordana-Comajuncosa
Journal:  Ann Rheum Dis       Date:  1990-11       Impact factor: 19.103

Review 5.  Autoimmunity and malignancy.

Authors:  G A McCarty
Journal:  Med Clin North Am       Date:  1985-05       Impact factor: 5.456

6.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

7.  A novel antinuclear antibody associated with a lupus-like paraneoplastic syndrome.

Authors:  B Freundlich; D Makover; G G Maul
Journal:  Ann Intern Med       Date:  1988-08-15       Impact factor: 25.391
  7 in total
  4 in total

Review 1.  Serologic laboratory findings in malignancy.

Authors:  Félix Fernández Madrid; Marie-Claire Maroun
Journal:  Rheum Dis Clin North Am       Date:  2011-11       Impact factor: 2.670

2.  A patient with a high titer of antinuclear antibody and a functioning adrenal tumour.

Authors:  M Zuber; R Miesel; B Brandl
Journal:  Clin Rheumatol       Date:  1995-01       Impact factor: 2.980

3.  Clinical correlation of anticentromere antibodies.

Authors:  M Zuber; R Gotzen; I Filler
Journal:  Clin Rheumatol       Date:  1994-09       Impact factor: 2.980

Review 4.  Paraneoplastic rheumatic syndromes.

Authors:  H J Mitnick
Journal:  Curr Rheumatol Rep       Date:  2000-04       Impact factor: 4.686
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.